Sahm ScreenerSaudi Stock Screenerفلتر الأسهم السعودية
Home / Dr. Sulaiman Al Habib Medical Services Group / 2024 Annual Results

Dr. Sulaiman Al Habib Medical Services Group 2024 Annual Results

Revenue
SAR 11.20B
Net Profit
SAR 2.32B
EPS
SAR 6.62
Operating Cash Flow
SAR 2.97B

Dr. Sulaiman Al Habib Medical Services Group (4013) reported full year 2024 revenue of SAR 11.20B, up 17.8% from SAR 9.51B in 2023. Net profit came in at SAR 2.32B, up 13.2% year on year. Earnings per share were SAR 6.62. The company generated SAR 2.97B in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.28 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.28.

Key Financial Metrics

Metric20242023
RevenueSAR 11.20BSAR 9.51B
Net ProfitSAR 2.32BSAR 2.05B
Net Margin20.7%21.5%
ROE32.3%31.6%
EPSSAR 6.62SAR 5.85
Total AssetsSAR 20.56BSAR 15.80B
Total EquitySAR 7.18BSAR 6.49B
Total LiabilitiesSAR 12.95BSAR 9.03B
Operating Cash FlowSAR 2.97BSAR 3.24B

Year on Year Comparison

Revenue increased by 17.8% compared to 2023. Net profit increased by 13.2%. Both revenue and profit grew — indicating expanding business.

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2025-02-16.